V

VYGR

Voyager Therapeutics Inc

3.40

-0.03-0.87%
After Hours: 3.383  -0.02  -0.49%16:44 05/20 EDT

Financial Statements

Statement:

Key indicator

Income Statement

Balance Sheet

Cash Flow

Reporting Period:

Accumulated Report

FY

YoY:
FY: Financial Year Annual Report
Q: Quarter is quarterly reports. Q1, Q2, Q3 and Q4 are reports for a single quarter. Q6 and Q9 are accumulated quarterly reports, respectively contain 6 months' reports and 9 months' report.
Item
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Total Revenue

80.00M

250.01M

40.91M

37.41M

171.13M

Net Income

-65.00M

132.33M

-46.41M

-71.20M

36.74M

ROE

-0.2425

0.8961

-0.6024

-0.571

0.2895

ROA

-0.1747

0.5183

-0.2628

-0.3127

0.1192

EPS

-1.1272

2.9691

-1.2099

-1.8901

0.9837

BVPS

5.4769

5.3662

1.5285

2.5068

4.1297

Asset Turnover

0.215

0.9792

0.2316

0.1643

0.5553

Debt-to-Asset

0.2373

0.3273

0.6296

0.5097

0.4101

Current Ratio

5.5598

4.9557

1.7151

2.6814

7.3888

Quick Ratio

--

--

--

--

--